Remove Doctors Remove Trials Remove Virus
article thumbnail

Coronavirus doctor's diary: Trying out tech that may help make worship Covid-secure

The Pharma Data

He also hears about a trial in the US to test whether prayer can help Covid patients in intensive care. He picked up the virus right at the start of the pandemic and had a relentless and gruelling illness followed by a lingering debilitation that has lasted over six months. This is no Mickey Mouse trial either. Front line diary.

Doctors 52
article thumbnail

Can a heartburn drug help doctors treat COVID-19?

The Pharma Data

In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis. But this method is expensive and can take years, Bourne pointed out.

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What FDA’s Newest Gene Therapy Approval Tells Us About Durability: How Long is Long Enough?

FDA Law Blog: Drug Discovery

We know, for example, the use of viral vectors results in antibody production that could inhibit future administration of gene therapies using the same or similar viruses, which will inform treatment decisions by patients with their doctors. Essentially, FDA was now asking for 18 months of data following treatment.

Therapies 119
article thumbnail

Keeping tabs on Covid-19: Iceni Diagnostics creates new virus detection device and the RDIF announce its vaccine is more than 95 per cent efficient

The Pharma Data

UK firm develops solution for identifying whether patients are actually infectious from a virus or not. Iceni Diagnostics has revealed it is developing a new technology that can disclose if patients are actually infectious with a live virus or not. Read on to for the full insight.

Vaccine 52
article thumbnail

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19. The DMC letter is available here: [link]. Department of Health and Human Services under OT number: HHSO100201700020C.

article thumbnail

Coronavirus antibodies tests 'put public at risk'

The Pharma Data

Poor regulation of antibodies tests – that could indicate if someone has had coronavirus – could be putting the public at risk, doctors have warned. “For drug licensing the onus is on the companies to go through clinical trials. Image copyright. Getty Images. Coronavirus immunity: Can you catch it twice?

article thumbnail

Recon: Pfizer plans COVID vaccine BLA submission this month; Gilead sues Russia over remdesivir comp

The Pharma Data

Big three drug distributors blame doctors, regulators in trial over opioid epidemic ( Reuters ). WHO is closely monitoring 10 Covid variants as virus mutates around the world ( CNBC ) . 2 respecting clinical trials for medical devices and drugs relating to COVID-19: Notice ( Health Canada ).

Vaccine 52